Calls Purchased on Sangamo BioSciences (SGMO)
February 14, 2011 11:26 AM
Shares of Sangamo BioSciences (NASDAQ: SGMO) are higher on the session by 3.32%, currently trading at $8.40. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages.
Options traders are buying calls on the name today. A short while ago the March 2011 $8.00 call was purchased 1,000 times, on the offer, on open interest of 2,493 contracts.
Overall call volume is now running at 2.41x the daily average with 93% of all calls traded being purchases on the offer.
Sangamo BioSciences, Inc. is engaged in development and commercialization of transcription factors for gene regulation and gene modification. Sangamo's gene regulation and gene modification technology platform is enabled by the engineering of a class of transcription factors known as zinc finger deoxyribonucleic acid (DNA) binding proteins (ZFPs).
